Format

Send to

Choose Destination
See comment in PubMed Commons below
J Psychiatry Neurosci. 1992 Nov;17(5):195-7.

The addition of intravenous caffeine during an amobarbital interview.

Author information

1
Department of Psychiatry, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27157.

Abstract

Although the amobarbital interview is an effective means of temporarily relieving catatonic mutism, some catatonic patients simply fall asleep during an amobarbital interview. We are examining the feasibility of administering intravenous caffeine benzoate during an amobarbital interview to prevent patients from falling asleep. This paper describes an open trial of the administration of 500 mg caffeine benzoate during amobarbital interviews with ten patients. The procedure was well tolerated, but further studies are needed to determine whether or not caffeine is an advantage over amobarbital alone.

PMID:
1489761
PMCID:
PMC1188455
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center